{"id":267,"date":"2008-01-17T16:45:00","date_gmt":"2008-01-17T16:45:00","guid":{"rendered":"https:\/\/wordpress-dev.med.unc.edu\/orthodev\/services\/tumors\/"},"modified":"2022-05-12T11:01:47","modified_gmt":"2022-05-12T15:01:47","slug":"tumors","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/ortho\/services\/tumors\/","title":{"rendered":"Orthopaedic Tumors"},"content":{"rendered":"

<\/p>\n

<\/p>\n

<\/p>\n

\"Tumor<\/p>\n

The Orthopaedic Oncology Service<\/b><\/span> at ºÚÁÏÍø Orthopaedics<\/a> features comprehensive, multidisciplinary cancer care. We offer the most up-to-date advances in screening methods, diagnostic tools, surgical techniques, and medical and radiation therapies. The overall goal of the program is to ensure that patients receive leading-edge, integrated specialty care for bone or soft tissue cancer. Until recently, most musculoskeletal cancers were considered to be rapidly fatal. However, advances in chemotherapy and radiation therapy have dramatically raised cure rates, while new types of joint replacement have improved patient function. Diagnostic advances have permitted the identification of separate malignant entities, which in turn has led to more specific treatments directed at individual tumor types. In addition to improved cure rates, limb saving operations can now be performed in approximately 90% of these tumors.<\/p>\n

Faculty and Staff<\/h2>\n
\n \n
\n
\n \t\t\n
\n \"Image\n \"\"\n <\/div>\t\t\t\t\t\t\t\t\t\n <\/div>\n
\n

\n Robert J. Esther, MD <\/a>\n <\/h2> \n \n

Vice Chair, Education and Professional Development
\nDivision Chief
\nH. Brashear Term Professor of Orthopaedic Surgery
\nProgram Director, Orthopaedic Residency Program
\nOrthopaedic Oncology<\/h4>\n <\/div>\n <\/article>\n\n \n